Terns Pharmaceuticals
TERN
TERN
44 hedge funds and large institutions have $50M invested in Terns Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less capital invested
Capital invested by funds: $117M → $50M (-$66.7M)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$371K | |
| 2 | +$364K | |
| 3 | +$201K | |
| 4 |
Millennium Management
New York
|
+$105K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$104K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$390K | |
| 3 | -$372K | |
| 4 |
Morgan Stanley
New York
|
-$238K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$97.3K |